Health Care: Drugs

AstraZeneca PLC (AZN: NYSE)

$33.78 -0.07 | -0.21%
07/25/17 - 04:02 PM ET
Company Income Statement
Dec 2016 Dec 2015 Dec 2014 Dec 2013
Sales 23.00B 24.71B 26.55B 25.81B
Cost of Sales 1.85B 1.91B 2.77B 678.00M
Gross Operating Profit 21.15B 22.80B 23.77B 25.13B
Selling, General, and Administrative Expenses 9.74B 11.45B 13.32B 12.51B
Research & Development 5.89B 6.00B 5.58B 4.82B
Operating Income before D & A (EBITDA) 5.52B 5.35B 4.87B 7.79B
Depreciation & Amortization 2.36B 2.85B 3.28B 4.58B
Interest Income 0.00 10.00M 16.00M 18.00M
Other Income - Net 1.07B 1.02B 409.00M 29.00M
Special Income / Charges 29.00M 21.00M -253.00M 500.00M
Total Income Before Interest Expenses (EBIT) 4.23B 3.54B 1.76B 3.76B
Interest Expense 680.00M 469.00M 510.00M 492.00M
Pre-Tax Income 3.55B 3.07B 1.25B 3.27B
Income Taxes 146.00M 243.00M 11.00M 696.00M
Minority Interest -93.00M 1.00M 2.00M 15.00M
Net Income From Continuing Operations 3.41B 2.83B 1.24B 2.57B
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 3.41B 2.83B 1.24B 2.57B
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 3.50B 2.83B 1.23B 2.56B
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
3.38B 2.81B 1.49B 2.07B
Preferred Dividends
Net Income Available To Common 3.41B 2.83B 1.24B 2.57B
Basic EPS from Continuing Ops. 1.39 1.12 0.49 1.02
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 1.39 1.12 0.49 1.02
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 1.39 1.12 0.49 1.02
Basic Normalized Net Income/Share 1.37 1.11 0.59 0.82
EPS fr Continuing Ops. 1.38 1.12 0.49 1.02
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 1.38 1.12 0.49 1.02
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 1.38 1.12 0.49 1.02
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
1.37 1.11 0.59 0.82
Dividends Paid per Share 1.40 1.40 1.40 1.40

Portfolios with AZN

Latest AZN Headlines from TheStreet

More Financial News for AZN

Press Releases for AZN

See All Press Releases
brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter